Brompheniramine Maleate/Phenylephrine Hydrochloride

Our study is a randomized controlled trial designed to evaluate the effects of Schroth-based three-dimensional exercise program on kyphosis angle, trunk muscle strength, balance parameters, pain and quality of life in individuals with postural hyperkyphosis with chronic neck pain. The aim of our study was to investigate the effects of Schroth 3 dimensional exercise program and posture corrective exercises on kyphosis angle, trunk extensor muscle strength, endurance, and balance in adults with postural kyphosis. The inclusion criteria are as follows; individuals aged 20-50 years with a thoracic kyphosis angle greater than 40 degrees, have neck pain for more than 3 months, participants with a visual analog scale value of 3 and above, no treatment for postural kyphosis in the last 6 months, individuals who do not have a systemic disorder will be included. Exclusion criteria; Participants with a history of trauma or surgery in the spine joints, rheumatologic and metabolic disorders, congenital postural deformity and scoliosis will not be included in the study. In our study, participants will be randomized into two groups using a computer program as Schroth-based three-dimensional exercise group and control group. Our study was planned as a Schroth-based three-dimensional exercise group and a control group for 8 weeks. Both groups will receive a total of 20 sessions of electrotherapy and exercise in the first 4 weeks. At the end of the 4th week, after the electrotherapy sessions are completed, exercise sessions will continue 3 days a week for the next 4 weeks. The study group will receive electrotherapy treatment (hot pack, ultrasound, tens) to the cervical and thoracic region for 30 minutes in each session. In the study group, kyphotic posture correction exercises will be applied. Patients to be included in the control group will receive electrotherapy treatment (ultrasound, tens, hotpack) to the neck area for 30 minutes in each session. Corrective exercises for posture will be applied to participants in the control group. Participants will be evaluated before the treatment, at the end of the 4th week and at the end of the treatment (at the end of the 8th week) by the physiotherapist performing the study.